In its recent 13F filing with the U.S. Securities and Exchange Commission, Route One Investment Company, managed by William Duhamel, has revealed its equity positions for the second quarter of 2014, reporting 10 holdings in its equity portfolio. The total value of Route One Investment Company’s portfolio amounted to more than $450 million, down from […]
In a newly amended filing with the U.S. Securities and Exchange Commission, 3G Capital, managed by Jorge Paulo Lemann, disclosed that it entered into a voting agreement related to the merger between Tim Hortons Inc. (USA) (NYSE:THI) and Burger King Worldwide Inc (NYSE:BKW). According to the filing, 3G Capital holds 243.86 million shares of Burger King […]
The Securities and Exchange Commission handed out its first whistleblower award to a compliance staffer on Friday.
If it ain’t broke, don’t fix it, right? That’s exactly what seed-stage venture firm Floodgate is thinking as it closes its fifth and new fund. According to a filing to the U.S. Securities and Exchange Commission, this fund of just under $76 million, more or less the same size as its previous two, is again headed by managing […]
Reading companies’ annual reports to the Securities and Exchange Commission is a reliable cure for insomnia. Every so often, though, there is a significant revelation in the paperwork.
In its latest 13F filing with the U.S. Securities and Exchange Commission, Bridger Management, run by Roberto Mignone, disclosed its holdings as held at the end of the second quarter of 2014. The fund reported 38 equity positions, with a total value of $1.42 billion. Over the quarter, the fund acquired eight positions, and sold […]
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014, the hedge fund revealed 132 equity positions, worth $8.5 billion. Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. […]
In a new filing with the U.S. Securities and Exchange Commission, Pershing Square, managed by Bill Ackman, has disclosed its and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) response to a recent announcement by Allergan Inc. (NYSE:AGN) regarding special meeting of stockholders and its court request to block Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Pershing Square from […]
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S. Securities and Exchange Commission that it further reduced its exposure to Achillion Pharmaceuticals Inc. (NASDAQ:ACHN). The filling showed that the hedge fund unloaded around 2.71 million shares of Achillion Pharmaceuticals Inc. Show More Summary
Soroban Capital Partners, led by Eric W. Mandelblatt, recently filed its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014. The fund disclosed ownership of 48 equity positions, worth more than $17 billion. Over the quarter, Horseman acquired more than 20 new stocks and sold out nine holdings. In […]
Abrams Bison Investments, a hedge run by Gavin Abrams, has filed its 13F with Securities and Exchange Commission, disclosing nine positions. Abrams, which founded the eponymous hedge-fund in 2000, is a value investor and generally focuses on long term investments and risk arbitrage. Historically he invests primarily in the US market. The current equity portfolio […]
In a newly amended filing with the U.S. Securities and Exchange Commission, Bill Gates’ Cascade Investment has disclosed a 28.7% stake in Republic Services Inc. (NYSE:RSG). According to the filing, Cascade Investment holds 102.2 million shares of the company. Recently, the fund reported acquiring 31,600 shares of Republic Services Inc. (NYSE:RSG). Cascade Investment has been […]
WASHINGTON—The Securities and Exchange Commission voted 3-2 to approve long-awaited rules designed to curb conflicts of interest at credit-rating firms, following criticism the firms failed to adequately sound alarms about flawed mortgage securities ahead of the financial crisis.
Mandel Ngan, AFP/Getty ImagesSecurities and Exchange Commission Chair Mary Jo White By MARCY GORDON WASHINGTON -- Financial firms that sell securities backed by loans, such as the kind that fueled the 2008 financial crisis, will have...Show More Summary
SEC’s civil case against SAC’s Cohen may get delayed again (NYPost) Manhattan US Attorney Preet Bharara has asked the Securities and Exchange Commission to hold off on its decision about former hedge-fund kingpin Steve Cohen for three more months. Bharara asked SEC chief administrative law judge Brenda Murray to continue the stay of the civil […]
Proceedings in the civil case against hedge fund investor Steven A. Cohen look set to be delayed yet again, according to a filing with the Securities and Exchange Commission.
Crosslink Capital, managed by Seymour Sy Kaufman and Michael Stark, continues to reduce its exposure to Pandora Media Inc. (NYSE:P). In a new filing with the U.S. Securities and Exchange Commission, Crosslink Capital disclosed that it sold 142,000 shares of the company in two transactions at approximately $27 apiece. Following the sale, Crosslink Capital still […]
In its latest filing with the U.S. Securities and Exchange Commission, Shannon River Fund Management, managed by Spencer M. Waxman, disclosed a 5.4% passive stake in LivePerson Inc. (NASDAQ:LPSN). According to the filing, Waxman currently owns 2.89 million shares of the company’s common stock. The stake represents an increase from 1.97 million shares the fund […]
As a new filing with the U.S. Securities and Exchange Commission showed, Christian Leone‘s Luxor Capital Group has inched up its position in Altisource Asset Management Corp (NYSEMKT:AAMC). The fund revealed holding a total of 400,215 shares, the stake being increased by around 27,400 shares acquired in several transactions. Show More Summary
As a new filing with the Securities and Exchange Commission showed, Sarissa Capital Management, a fund led by Alex Denner, has picked up its position in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) to 12.85 million shares, from 12.0 million disclosed previously. Show More Summary